影像 CRO 市場按服務類型、影像方式、治療領域、臨床試驗階段、最終用戶和地區分類

2025 年全球影像 CRO 市場規模估計為 56.1 億美元，預計到 2032 年將達到 96.8 億美元，2025 年至 2032 年的複合年成長率為 8.1%。

全球影像 CRO 市場已成為醫療保健產業的關鍵領域，在醫學成像技術的開發和開拓中發揮關鍵作用。影像 CRO（合約研究組織）專門提供廣泛的服務，包括影像通訊協定設計、影像擷取、分析和解釋，以支援臨床試驗和研究。這些組織利用尖端技術和專業知識來提供高品質的影像數據，使製藥和生物技術公司能夠在藥物開發過程中做出明智的決策。慢性病的增加、對個人化醫療的不斷成長的需求以及對高效且具有成本效益的藥物開發的需求正在推動全球影像 CRO 市場的成長。隨著醫療保健格局的不斷發展，影像 CRO 在加速創新治療方法的開發和改善患者預後方面的作用變得越來越重要。

市場動態

全球影像 CRO 市場的成長受到多種關鍵因素的驅動，例如慢性病的流行、對先進成像技術不斷成長的需求，以及對高效且經濟的藥物開發流程日益成長的需求。人口老化和生活方式的改變使癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升，這些疾病需要先進的影像技術進行診斷和監測。此外，個人化醫療的出現使得標靶治療的發展成為必要，而標靶治療在很大程度上依賴影像生物標記來選擇患者和評估治療反應。然而，影像設備高成本、監管要求複雜以及該領域熟練專業人員短缺等因素可能會抑制市場成長。

此外，影像方案和資料管理缺乏標準化，也為影像合約研究組織 (CRO) 帶來挑戰，使其難以確保不同機構和研究之間影像資料的可靠性和可重複性。儘管面臨這些挑戰，但人工智慧、機器學習和雲端運算等技術進步正在改變診斷影像領域，市場也提供了巨大的成長機會。這些技術能夠更快、更準確地進行影像分析，簡化資料管理，並促進相關人員之間的遠端協作。此外，PET/CT 和 PET/MRI 等混合影像模式的日益普及，預計將擴大影像合約研究組織 (CRO) 支援多模態影像研究的範圍。

本研究的主要特點

• 本報告對全球影像 CRO 市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
• 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
• 全球成像 CRO 市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。
• 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
• 全球成像 CRO 市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
• 相關人員可以透過用於分析全球成像 CRO 市場的各種策略矩陣來更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 驅動程式
• 限制因素
• 機會
• 影響分析
• 主要進展
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景
• 產業趨勢

4. 2020 年至 2032 年全球影像 CRO 市場（依服務類型）

• 臨床試驗影像
• 臨床前影像
• 醫學影像資料管理
• 影像處理與分析服務
• 監理諮詢
• 其他（品管等）

5. 2020 年至 2032 年全球影像 CRO 市場（以影像方式分類）

• 磁振造影（MRI）
• 電腦斷層掃描（CT）
• 正子斷層掃描（PET）
• 超音波
• X光
• 光學成像

6. 2020 年至 2032 年按治療領域分類的全球影像 CRO 市場

• 腫瘤學
• 神經病學
• 心臟病學
• 肌肉骨骼疾病
• 胃腸病學
• 內分泌學
• 其他

7. 2020 年至 2032 年按臨床試驗階段分類的全球影像 CRO 市場

• 第一階段
• 第二階段
• 第三階段
• 第四階段

8. 2020 年至 2032 年全球影像 CRO 市場（依最終使用者分類）

• 製藥公司
• 生技公司
• 醫療設備製造商
• 診斷中心
• 受託研究機構
• 學術研究所

9. 全球影像 CRO 市場（按地區分類），2020 年至 2032 年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中部非洲

第10章 競爭格局

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Canon Medical Systems
• Fujifilm Holdings Corporation
• Agfa-Gevaert Group
• Hitachi Medical Corporation
• Carestream Health
• Hologic, Inc.
• Toshiba Medical Systems
• Mindray Medical International Limited
• Varian Medical Systems
• Esaote SpA
• Bracco Imaging SpA
• Leica Biosystems

第 11 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第12章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Imaging CRO Market is estimated to be valued at USD 5.61 Bn in 2025 and is expected to reach USD 9.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.

The global imaging CRO market has emerged as a crucial sector within the healthcare industry, playing a pivotal role in the development and advancement of medical imaging technologies. Imaging Contract Research Organizations (CROs) specialize in providing a wide range of services, including imaging protocol design, image acquisition, analysis, and interpretation, to support clinical trials and research studies. These organizations leverage cutting-edge technologies and expertise to deliver high-quality imaging data, enabling pharmaceutical and biotechnology companies to make informed decisions during the drug development process. The increasing prevalence of chronic diseases, coupled with the growing demand for personalized medicine and the need for efficient and cost-effective drug development, has fueled the growth of the global imaging CRO market. As the healthcare landscape continues to evolve, the role of imaging CROs is becoming increasingly important in accelerating the development of innovative therapies and improving patient outcomes.

Market Dynamics

The global imaging CRO market growth is driven by several key factors, including the increasing prevalence of chronic diseases, rising demand for advanced imaging technologies, and the growing need for efficient and cost-effective drug development processes. The aging population and changing lifestyles have led to a higher incidence of chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which require advanced imaging techniques for diagnosis and monitoring. Additionally, the advent of personalized medicine has necessitated the development of targeted therapies, which rely heavily on imaging biomarkers for patient selection and treatment response assessment. However, the market growth may be restrained by factors such as the high cost of imaging equipment, complex regulatory requirements, and the shortage of skilled professionals in the field.

Furthermore, the lack of standardization in imaging protocols and data management poses challenges for imaging CROs in ensuring the reliability and reproducibility of imaging data across different sites and studies. Despite these challenges, the market presents significant opportunities for growth, driven by technological advancements such as artificial intelligence, machine learning, and cloud computing, which are transforming the imaging landscape. These technologies enable faster and more accurate image analysis, streamline data management, and facilitate remote collaboration among stakeholders. Moreover, the increasing adoption of hybrid imaging modalities, such as PET/CT and PET/MRI, is expected to expand the scope of Imaging CROs in supporting multimodal imaging studies.

Key Features of the Study

• This report provides in-depth analysis of the global imaging CRO market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Imaging CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, Fujifilm Holdings Corporation, Agfa-Gevaert Group, Hitachi Medical Corporation, Carestream Health, Hologic, Inc., Toshiba Medical Systems, Mindray Medical International Limited, Varian Medical Systems, Esaote S.p.A., Bracco Imaging S.p.A., and Leica Biosystems
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global imaging CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global imaging CRO market

Market Segmentation

• Service Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Clinical Trial Imaging
  • Preclinical Imaging
  • Medical Imaging Data Management
  • Image Processing & Analysis Services
  • Regulatory Consultancy
  • Others (Quality Control, etc.)
• Imaging Modality Insights (Revenue, USD Bn, 2020 - 2032)
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Optical Imaging
• Therapeutic Area Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Neurology
  • Cardiology
  • Musculoskeletal Disorders
  • Gastroenterology
  • Endocrinology
  • Others
• Clinical Trial Phase Insights (Revenue, USD Bn, 2020 - 2032)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Diagnostic Centers
  • Contract Research Organizations
  • Academic and Research Institutes
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • Canon Medical Systems
  • Fujifilm Holdings Corporation
  • Agfa-Gevaert Group
  • Hitachi Medical Corporation
  • Carestream Health
  • Hologic, Inc.
  • Toshiba Medical Systems
  • Mindray Medical International Limited
  • Varian Medical Systems
  • Esaote S.p.A.
  • Bracco Imaging S.p.A.
  • Leica Biosystems

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Imaging CRO Market, By Service Type
  • Global Imaging CRO Market, By Imaging Modality
  • Global Imaging CRO Market, By Therapeutic Area
  • Global Imaging CRO Market, By Clinical Trial Phase
  • Global Imaging CRO Market, By End User
  • Global Imaging CRO Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Imaging CRO Market, By Service Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Clinical Trial Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Preclinical Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Imaging Data Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Image Processing & Analysis Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regulatory Consultancy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Quality Control, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Imaging CRO Market, By Imaging Modality, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Magnetic Resonance Imaging (MRI)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Computed Tomography (CT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Positron Emission Tomography (PET)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ultrasound
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• X-ray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Optical Imaging
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Imaging CRO Market, By Therapeutic Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Musculoskeletal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Imaging CRO Market, By Clinical Trial Phase, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Phase I
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase III
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Phase IV
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Imaging CRO Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medical Device Manufacturers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Imaging CRO Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Imaging Modality, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Clinical Trial Phase, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Philips Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Canon Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujifilm Holdings Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agfa-Gevaert Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hitachi Medical Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carestream Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Toshiba Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mindray Medical International Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Varian Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Esaote S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bracco Imaging S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Leica Biosystems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us